Innovative Diagnostic Solutions QuidelOrtho's focus on developing intelligent and rapid diagnostic tools, such as the QUICKVUE Influenza + SARS Test and point-of-care solutions, positions it well to serve healthcare providers looking for quick, reliable testing options, especially in response to ongoing infectious disease demands.

Expanding Rural Access The launch of the Certified Analyzer Program aims to increase diagnostic testing availability in rural and community hospitals across the United States, creating opportunities for sales of portable and high-quality diagnostic analyzers tailored to underserved markets.

Market Leadership & Recognition Receiving awards for excellence in EMEA and recognition in transfusion medicine events highlights QuidelOrtho’s strong reputation and credibility, making it an attractive partner for health systems seeking proven, award-winning diagnostic solutions.

Product & Service Diversification The company's recent launches of new assays and participation in multimedia outreach through podcasts demonstrate its commitment to innovation and thought leadership, providing multiple avenues to engage healthcare organizations interested in the latest diagnostic advancements.

Strategic Growth & Collaborations With substantial revenue and funding in the mid-billions, along with partnerships like BÜHLMANN, QuidelOrtho is positioned to expand its product portfolio and enter new markets, offering targeted sales opportunities for diagnostic reagents, assays, and associated services.